Actavis has launched its Isotretinoin product under the brand name Zoretanin in Turkey. Zoretanin is currently the only generic Isotretinoin available in this market.

Zoretanin is a prescription drug and is indicated for the treatment of severe acne, which does not respond to other treatments. It contains the active substance Isotretinoin, which belongs to the group of drugs called retinoids, which are structurally related to vitamin A. It reduces the activity of sebaceous glands, which produce fat in the skin. Zoretanin was launched to Dermatologists in Turkey on 19 September in 10mg and 20 mg capsules.

At the same time Actavis has also launched a generic version of Glimepiride, originally released by Aventis Pharma under the brand name Amaryl. The Actavis brand name in Turkey is Diaglin. Used to treat type 2 diabetes, the drug is available in 1mg, 2mg, 3mg and 4mg tablets.

The launch of Zoretanin and Diaglin demonstrates Actavis’ ongoing commitment to the growing Turkish market. Products launched by Actavis in Turkey in the past 12 months include generic versions of Paroxetine, Ramipril, Fexofenadine and Alendronic Acid.

Worldwide, Actavis has over 650 products on the Group’s markets, and over 350 products under development and pending registration. 40-45 ANDAs are expected in the US market in 2007. Actavis products are registered in more than 60 countries and over 500 product and market launches are expected in Group markets in 2007.